CXCL9 and melanoma: In mouse melanoma models, eosinophil recruitment induced by Tregs depletion [190] or by IL-33 treatment [191] mediated melanoma regression through production of CD8+ T cell attracting chemokines (i.e., CXCL9, CCL10 and CCL5) by promoting tumor-reactive CD8+ T cell responses.